tnbc: updated efficacy results from impassion130
Published 4 years ago • 66 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
2:51
impassion130: design and preliminary efficacy
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
4:33
i-o in tnbc: impassion130 trial design and results
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
2:33
applying impassion130 data to tnbc management
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
1:39
dr. rugo on takeaways from the impassion130 trial in tnbc
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
1:46
dr. schmid discusses the findings of impassion130 in tnbc
-
4:27
the impassion130 study in metastatic tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer